Actively Recruiting
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Led by TriHealth Inc. · Updated on 2025-02-25
166
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
CONDITIONS
Official Title
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing any pelvic organ prolapse repair or incontinence surgery
You will not qualify if you...
- Surgery involving a non-urogynecologist
- Current use of alpha blocker medication
- Baseline low blood pressure (hypotension)
- History of fainting (syncope)
- Postural orthostatic tachycardia syndrome (POTS)
- Non-English speaking without available interpreter for Spanish
- Cognitive impairment preventing proper consent
- Any medical reason preventing tamsulosin use
- History of urinary retention needing catheterization
- Pregnancy
- Intraoperative complications requiring catheter use or voiding trial no longer indicated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
TriHealth
Cincinnati, Ohio, United States, 45220
Actively Recruiting
Research Team
G
Gisele C Moran, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here